The European Parliament adopted on Wednesday 24 November the report by Dolors Montserrat (EPP, Spain) on the EU’s new pharmaceutical strategy.
The text was backed by a large majority of MEPs (527 votes in favour, 92 against and 70 abstentions), despite some criticism raised by several groups in a plenary debate on Monday about the provisions relating to the pharmaceutical industry (see EUROPE B12838A13).
The Left - with the exception of six of its members - notably followed its...